Japanese Patent Grant for Medical Marketing International Group plc's Genvax Vaccines and Board Change
20 August 2007 - Medical Marketing International Group plc (MMI or the
'Company') (AIM:MMG), the pharmaceutical company focused on the development of drugs for cancer and infectious diseases, today announces that it has been notified by the Japanese Patent Office of the grant of a patent that protects its cancer vaccine technology. The patent will be granted following the payment of standard fees.